Literature DB >> 1131608

Cost-benefit analysis of long-term haemodialysis for chronic renal failure.

M J Buxton, R R West.   

Abstract

A cost-benefit analysis of long-term maintenance haemodialysis indicates that there is a large gulf between the cost of the service and "economic" benefit. The difference may be considered to represent one estimate of the price society is prepared to pay to maintain life. Using "best estimates" from available data we found the implicit social value of maintaining a patient on haemodialysis to be approximately pounds 4720 per annum in hospital or pounds 2600 at home. The analysis would suggest that society must look carefully at alternative uses for health expenditure before extending indiscriminately to large sections of the population these treatment programmes or other similarly expensive.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  1975        PMID: 1131608      PMCID: PMC1673150          DOI: 10.1136/bmj.2.5967.376

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  A mathematical model of an integrated haemodialysis and renal transplantation programme.

Authors:  R R West; D L Crosby; J H Jones
Journal:  Br J Prev Soc Med       Date:  1974-08

2.  Survey of chronic renal failure in Scotland.

Authors:  D M Pendreigh; L F Howitt; A J Macdougall; J S Robson; M A Heasman; A C Kennedy; M MacLeod; W K Stewart
Journal:  Lancet       Date:  1972-02-05       Impact factor: 79.321

3.  Chronic renal failure in Northern Ireland, 1968-70. A prospective survey.

Authors:  M G McGeown
Journal:  Lancet       Date:  1972-02-05       Impact factor: 79.321

4.  Regular haemodialysis.

Authors:  D N Kerr
Journal:  Proc R Soc Med       Date:  1967-11

5.  Incidence of uraemia and requirements for maintenance haemodialysis.

Authors:  R A Branch; G W Clark; A L Cochrane; J H Jones; H Scarborough
Journal:  Br Med J       Date:  1971-01-30
  5 in total
  11 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Letter: Screening for Down's syndrome.

Authors:  R R West
Journal:  Br Med J       Date:  1976-05-22

Review 3.  Discounting the future: influence of the economic model.

Authors:  R R West
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

4.  Discounting the future: influence of the economic model.

Authors:  T Marshall
Journal:  J Epidemiol Community Health       Date:  1997-06       Impact factor: 3.710

5.  Valuation of life in long run health care programmes.

Authors:  R R West
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-19

6.  Essentials of health economics. Part V--Assessing the costs and benefits of treatment alternatives.

Authors:  M F Drummond; G H Mooney
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

7.  Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area.

Authors:  M J Dwyer; P G McIntyre
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

Review 8.  How to overcome barriers and establish a successful home HD program.

Authors:  Bessie A Young; Christopher Chan; Christopher Blagg; Robert Lockridge; Thomas Golper; Fred Finkelstein; Rachel Shaffer; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

9.  Haemophilia A and the blood transfusion service: a Scottish study.

Authors:  J D Cash; M Spencely
Journal:  Br Med J       Date:  1976-09-18

10.  Triage and the patient with renal failure.

Authors:  V Parsons; P Lock
Journal:  J Med Ethics       Date:  1980-12       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.